A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- NCT ID
- NCT07723833
- Registry status
- Recruiting
- Study type
- Not specified in the registry data
- Phase
- Phase 1
- Sponsor
- AstraZeneca
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 152 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Healthy participants with suitable veins for cannulation or repeated venipuncture.
* All females must have a negative pregnancy test at the Screening Visit and on admission to the Clinical Unit.
* Females of childbearing potential must not be lactating and if heterosexually active, must agree to use an approved method of highly effective contraception.
* Females of non-childbearing potential must be confirmed at screening visit as postmenopausal or have documentation of irreversible surgical sterilization.
* Sexually active fertile male participants with partners of childbearing potential must adhere to the study specific contraception methods.
* Have a body mass index between 18.5 and 30 kg/m2 inclusive and weigh at least 50 kg.
Exclusion Criteria:
* History of any clinically important disease or disorder.
* History of acute pancreatitis.
* History or presence of gastrointestinal (GI) or any other condition known to interfere with absorption, distribution, metabolism, or excretion of drugs.
* Clinically significant inflammatory bowel disease, gastroparesis, severe disease, or surgery affecting the upper GI tract.
* Any clinically important illness, medical/surgical procedure, or trauma.
* Participants who have previously received elecoglipron within the last 3 months.
Study locations
2 study locations are listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- California, United States: 1
- Maryland, United States: 1
Sample of listed locations
- Research Site — Glendale, California, 91206, United States — Site recruitment status not specified in the registry data
- Research Site — Brooklyn, Maryland, 21225, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- July 27, 2026
- Primary completion date
- November 18, 2026
- First posted
- July 23, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07723833
- Registry last updated
- September 16, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07723833 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ